Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment

NCT: NCT06039085 · RECRUITING

NCT IDNCT06039085
StatusRECRUITING
Start Date2023-11-03
Completion2027-12-31

Brief Summary

This research will study a custom device developed to detect if any prostate cancer tissue is left behind when the prostate is removed. This device is called an Electrical Impedance Imaging (EII) probe.

Frequently Asked Questions

What is Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment?

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment is a clinical trial registered under NCT06039085. Current status: RECRUITING.

What is the status of NCT06039085?

The current status of NCT06039085 (Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment) is: RECRUITING.

When did Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment start?

Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment started on 2023-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑